Document

Recombinant DNA Advisory Committee; Notice of Meeting

[Federal Register Volume 63, Number 245 (Tuesday, December 22, 1998)] [Notices] [Pages 70789-70790] From the Federal Register Online via the Government Publishing Office [ www.g...

[Federal Register Volume 63, Number 245 (Tuesday, December 22, 1998)]
[Notices]
[Pages 70789-70790]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-33766]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Recombinant DNA Advisory Committee; Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given of a meeting 
of the Recombinant DNA Advisory Committee on January 7, 1999. The 
meeting will be held at the Hyatt Regency Bethesda Hotel, One Bethesda 
Metro Center, Bethesda, Maryland 20814, starting at approximately 5:30 
p.m. and will adjourn at approximately 9:30 p.m. The meeting will be 
open to the public to discuss human gene transfer protocols, 
procedures, data management, and other matters to be considered by the 
Committee. Attendance by the public will be limited to space available.
    Debra W. Knorr, Deputy Director, Office of Recombinant DNA 
Activities, National Institutes of Health, MSC 7010, 6000 Executive 
Boulevard, Suite 302, Bethesda, Maryland 20892-7010, Phone 301-496-
9838, Fax 301-496-9839, will provide summaries of the meeting and a 
roster of committee members upon request. Individuals who plan to 
attend and need special assistance, such as sign language 
interpretation or other reasonable accommodations, should contact Ms. 
Knorr in advance of the meeting. OMB's ``Mandatory

[[Page 70790]]

Information Requirements for Federal Assistance Program Announcements'' 
(45 FR 39592, June 11, 1980) requires a statement concerning the 
official government programs contained in the Catalog of Federal 
Domestic Assistance. Normally NIH lists in its announcements the number 
and title of affected individual programs for the guidance of the 
public. Because the guidance in this notice covers virtually every NIH 
and Federal research program in which DNA recombinant molecule 
techniques could be used, it has been determined not to be cost 
effective or in the public interest to attempt to list these programs. 
Such a list would likely require several additional pages. In addition, 
NIH could not be certain that every Federal program would be included 
as many Federal agencies, as well as private organizations, both 
national and international, have elected to follow the NIH Guidelines. 
In lieu of the individual program listing, NIH invites readers to 
direct questions to the information address above about whether 
individual programs listed in the Catalog of Federal Domestic 
Assistance are affected.

    Dated: December 15, 1998.
LaVerne Y. Stringfield,
Committee Management Officer, NIH
[FR Doc. 98-33766 Filed 12-21-98; 8:45 am]
BILLING CODE 4140-01-M


Legal Citation

Federal Register Citation

Use this for formal legal and research references to the published document.

63 FR 70789

Web Citation

Suggested Web Citation

Use this when citing the archival web version of the document.

“Recombinant DNA Advisory Committee; Notice of Meeting,” thefederalregister.org (December 22, 1998), https://thefederalregister.org/documents/98-33766/recombinant-dna-advisory-committee-notice-of-meeting.